Dr. Vinodh Kumar
Senior Post-Doctoral Research Scientist, at Center for Health Disparities in Molecular Medicine, Loma Linda University, School of Medicine, California, USA.

Dr.Vinodh Kumar (VIN) Radhakrishnan currently working as a Senior Post-Doctoral Research Scientist, at Center for Health Disparities in Molecular Medicine, Loma Linda University, School of Medicine, California, USA. Broad area of research specialization in Lung Cancer, Triple Negative Breast Cancer (TNBC), Methylation, Mitochondrion, Drug discovery and Epigenetics. Primary focus towards precision and personalized medicine which is the future of medicine. Conducted routine-to-complex experiments and critical analysis of research data in generating summary reports, project proposals and submit publications to international scientific journals and related patents.

Trained MD / B.Tech students on teaching and handling research techniques related to Genomics, Proteomics, Metabolomics, Biochemistry, Molecular biology and Microbiology in triggering the young minds towards scientific profession. As a visiting scientist worked in City of Hope National Medical Center, Duarte, CA, USA. National Cancer Institute (NCI) designated cancer center in department of Molecular Medicine, under top scientific teams and gained hope into the research career as young scientist in studying the life science behind the human cancers and understanding early diagnosis and related treatments.

Early phase of his PhD research, worked and collaborated with various top South Korean Universities and Madras University in performing his PhD research and was awarded the International Brain Korea 21 fellowship to perform research related to Lung Cancer and Leukemia with histone deacetylase treatments with major key publications and the thesis was highly awarded. This shows his track record of working in cancer research team and collaborations across international levels.

Dr. Venkata Ramanarao PARASA
Principal Research Scientist at Linköping University, SWEDEN.

Dr. Venkata Ramanarao PARASA is a Principal Research Scientist at Linköping University, SWEDEN. His research interests are diagnosis, assay development and host-directed therapy. After completing PhD in 2010 at University of Madras, INDIA, Ramana was invited to Karolinska Institute, SWEDEN as a Postdoctoral Research Scientist, where he developed in vitro human tissue models based on primary cells and cancer cells. Later, Ramana joined Linköping University, SWEDEN and is currently a Principal Research Scientist investigating chemo-resistance of breast cancer, epigenetic training of immunity and host-directed therapy for respiratory infections. He is primarily accountable for planning, managing and executing several research projects with ownership of writing grant applications and liaising within team and collaborators across multiple disciplines for timely completion.

His notable accomplishments include Fellowships from Indian Council of Medical Research and Lady Tata Memorial Trust; publication of book on diagnostics and several peer-reviewed research articles; Expert Reviewer for Drug Discovery Today Journal and Editorial Board member for Journal of Academia and Industrial Research; and Investigator for two project grants from Swedish Research Council.

Ramana associated with Sankalp Beautiful World with the aim of discovering point-of-contact tests to cancer. Presently, Ramana is an Expert Advisor to Sankalp Beautiful World and is responsible for drafting SOPs for the organization and writing fund-seeking applications.

Dr.Vijayalakshmi Ramshankar
Associate Professor at the Cancer Institute ( WIA) Adyar, Chennai.

Dr Vijayalakshmi Ramshankar is working as an Associate Professor in the Department of Preventive Oncology, heading the research division at the Cancer Institute ( WIA) Adyar, Chennai. She is a doctorate in molecular oncology and completed her post doctoral tenures at prestigious Indian Institute of Science, Bangalore and Columbia University, Newyork, United States. She is currently a faculty scientist of the reputed Cancer Institute (WIA) and has a vast experience of the more than 25 years in the field on molecular oncology. Her primary focus is on tobacco related cancers like Oral, lung cancers and Human papilloma virus (HPV) based screening for cervical cancer. Her objective is to translate oncology research to patient bedside in the form of prognostic and predictive biomarkers that can be useful for screening, early detection and disease monitoring.

Dr Vijayalakshmi also uses her skill and expertise for molecular diagnostics. Her laboratory expertise is helpful for cancer patients in the various molecular tests such as HLA typing for bone marrow transplants, EGFR and other mutation testing for lung cancers, infectious diseases testing like CMV, HBV, HCV etc.

She has been the recipient of the prestigious Lady Tata Memorial Fellowship for doctoral studies, Dept of Biotechnology fellowship for postdoctoral studies, recipient of gold medal for best research in Oral cancer from FHNO (Foundation of Head and Neck Oncology). With more than 50 papers in international and national journals and 4 book chapters, Dr Vijayalakshmi additionally guides Ph.D students and helps in building the skill set for the young postgraduates in her laboratory. Dr Vijayalakshmi is in scientific advisory panels of several reputed academic institutions including IIT Madras, Sri Ramachandra Deemed University, Tamilnadu Dr MGR Medical University and Vellore Institute of Technology.    

Dr.Bharanidharan Devarajan
Omics Scientist, Aravind Medical Research Foundation
Dr. Bharanidharan Devarajan, is a scientist in the Departments of  Bioinformatics and Ocular Microbiology, at the Aravind Medical Research Foundation, Madurai, India. Dr. Bharani, specializes in ocular cancer bioinformatics and systems biology, analysis of genome-wide expression profiles of mRNA and non-coding RNAs, biological pathway analysis, and computational analysis of alternate transcripts.  Dr. Bharani earned his Bachelor's and Master's degree in Biochemistry from University of Madras. He received his Ph. D (2007) in Computational Biology and X-ray crystallography from the Centre for Crystallography and Biophysics at University of Madras. He then pursued his Postdoctoral research at University of Alabama, Birmingham, USA (2008-2010) and Georgia Institute of Technology, Atlanta, USA (2010-2012). Dr. Bharani's main research interest is in translational genomics of various eye disease and ocular cancer, to understanding the complexity of biological processes and to identify diagnostic molecular markers for more effective and personalized therapies. His research is to seek an agile and predictive understanding of how genetic variants and alternate transcripts that results Retinoblastoma, and other ocular cancers including lymphoma, melanoma using DNA microarrays and next generation sequencing. eye diseases including ocular cancers. In tandem, his lab is also developing mRNA and microRNA biomarkers of Retinoblastoma tumor progression, recurrence in ocular lymphoma, and other ocular diseases. His lab analyzes whole exome/genome dataset, genome-wide expression profiles, alternate transcripts networks, biological pathways to get critical answers faster.